Filing Details

Accession Number:
0001615219-16-000228
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-07 16:40:39
Reporting Period:
2016-11-07
Filing Date:
2016-11-07
Accepted Time:
2016-11-07 16:40:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1615219 Flex Pharma Inc. FLKS Pharmaceutical Preparations (2834) 465087339
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1630720 P. John Mccabe C/O Flex Pharma, Inc.
800 Boylston Street
Boston MA 02199
Vp Of Finance & Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-07 1,650 $6.01 1,650 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price in Column 4 is a weighted average purchase price. The prices actually received ranged from $5.99 to $6.01. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.